V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240015636 | 240006841 | 1.63 | 77 | null | 2014-11-10 | 2014-11-14 | CHOP R - 21 days | N | N | 240024617 | CHOP R |
| 240015637 | 240006853 | null | null | Curative (C) | 2018-03-29 | 2018-05-17 | Bendamustine+Rituximab (1st Course) | N | null | 240024682 | BENDAMUSTINE + RITUXIMAB |
| 240015638 | 240006856 | null | null | Curative (C) | 2015-06-17 | 2015-06-17 | CHOP R - 21 days | N | null | 240024708 | CHOP R |
| 240015639 | 240011697 | 1.78 | 58.6 | Curative (C) | 2016-10-05 | 2016-10-11 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240024721 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240015640 | 240015164 | 1.67 | 45.8 | null | 2016-04-25 | 2016-04-27 | CISPLATIN + RT | 2 | N | 240024824 | CISPLATIN + RT |
| 240015641 | 240006899 | 1.67 | 87 | Curative (C) | 2019-01-13 | 2019-01-28 | Cisplatin + Radiotherapy | N | Y | 240025075 | CISPLATIN + RT |
| 240015642 | 240006914 | 1.8 | 47.3 | Palliative (P) | 2017-06-21 | 2017-06-21 | CARBOPLATIN + PACLITAXEL | 2 | N | 240025189 | CARBOPLATIN + PACLITAXEL |
| 240015643 | 240006933 | 1.69 | null | Palliative (P) | 2017-04-28 | 2017-05-12 | CARBOPLATIN + PACLITAXEL | N | N | 240025320 | CARBOPLATIN + PACLITAXEL |
| 240015644 | 240006934 | 1.51 | 78 | Palliative (P) | 2018-02-05 | 2018-02-24 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 240025330 | CARBOPLATIN + PACLITAXEL |
| 240015645 | 240006940 | null | 73 | Palliative (P) | 2018-06-13 | 2018-06-21 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240025346 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240015646 | 240006951 | 1.78 | 50.5 | Palliative (P) | 2018-11-03 | 2018-11-24 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240025449 | CARBOPLATIN + PACLITAXEL |
| 240015647 | 240014021 | 1.8 | 72.5 | Palliative (P) | 2015-09-13 | 2015-09-13 | CARBOPLATIN + PACLITAXEL | 02 | N | 240025467 | CARBOPLATIN + PACLITAXEL |
| 240015648 | 240011750 | 1.51 | 68 | Curative (C) | 2015-11-07 | 2015-11-30 | Cisplatin + Radiotherapy | N | N | 240025473 | CISPLATIN + RT |
| 240015649 | 240006973 | 1.8 | 89.7 | Neo-adjuvant (N) | 2018-07-04 | 2018-07-23 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240025602 | CARBOPLATIN + PACLITAXEL |
| 240015650 | 240006985 | 1.65 | 52.4 | Palliative (P) | 2019-03-30 | 2019-04-04 | Carboplatin + Paclitaxel (3 weekly) | 2 | null | 240025659 | CARBOPLATIN + PACLITAXEL |
| 240015651 | 240006997 | 1.68 | 67.4 | Palliative (P) | 2019-08-18 | 2019-09-13 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240025746 | CARBOPLATIN + PACLITAXEL |
| 240015652 | 240007002 | 1.6 | 50.8 | Disease modification (D) | 2014-07-04 | 2014-07-05 | CVP R | 2 | N | 240025774 | CVP R |
| 240015654 | 240007018 | 1.56 | 64 | Curative (C) | 2017-08-04 | 2017-09-23 | Cisplatin + Radiotherapy | N | N | 240025903 | CISPLATIN + RT |
| 240015655 | 240007021 | 1.6 | 68.8 | Adjuvant (A) | 2016-06-09 | 2016-08-23 | CISPLATIN + RT | N | Y | 240025904 | CISPLATIN + RT |
| 240015656 | 240007025 | 1.72 | 36 | Neo-adjuvant (N) | 2018-08-27 | 2018-08-29 | CVP R | 02 | N | 240025909 | CVP R |
| 240015657 | 240011796 | null | 74.3 | Palliative (P) | 2018-02-07 | 2018-03-07 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240026073 | CARBOPLATIN + PACLITAXEL |
| 240015658 | 240007048 | 1.73 | 54 | Curative (C) | 2017-06-11 | 2017-06-13 | CVP R | 2 | N | 240026144 | CVP R |
| 240015659 | 240007050 | 1.47 | 65.4 | Palliative (P) | 2015-06-20 | 2015-07-30 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240026156 | CARBOPLATIN + PACLITAXEL |
| 240015660 | 240007053 | 1.76 | 105 | Palliative (P) | 2013-08-07 | 2013-08-08 | R GCVP | 2 | N | 240026170 | CVP R |
| 240015661 | 240011808 | 1.72 | 61 | Palliative (P) | 2014-06-10 | 2014-06-16 | Cisplatin + Radiotherapy | 02 | N | 240026183 | CISPLATIN + RT |
| 240015662 | 240007062 | 1.57 | 50.3 | Palliative (P) | 2017-06-02 | 2017-07-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240026242 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240015663 | 240007089 | null | 55 | Curative (C) | 2015-01-08 | 2015-01-08 | Cisplatin + Radiotherapy | N | Y | 240026508 | CISPLATIN + RT |
| 240015664 | 240007108 | 1.73 | 76.8 | Palliative (P) | 2014-08-27 | 2015-05-07 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240026622 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240015665 | 240007134 | 1.6 | 71 | Curative (C) | 2017-03-03 | 2017-03-08 | Cisplatin + Radiotherapy | N | y | 240026834 | CISPLATIN + RT |
| 240015666 | 240007151 | 1.75 | 71 | Palliative (P) | 2018-05-14 | 2018-07-22 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240027011 | CARBOPLATIN + PACLITAXEL |
| 240015667 | 240007169 | 1.6 | null | Curative (C) | 2018-08-29 | 2018-08-31 | CARBOPLATIN + PACLITAXEL | N | N | 240027128 | CARBOPLATIN + PACLITAXEL |
| 240015668 | 240007182 | 1.6 | 56 | Palliative (P) | 2017-08-10 | 2017-11-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240027239 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240015669 | 240007197 | 1.75 | null | Disease modification (D) | 2017-09-26 | 2017-10-27 | Cisplatin + Radiotherapy | N | N | 240027366 | CISPLATIN + RT |
| 240015670 | 240007203 | 1.54 | 55.6 | Curative (C) | 2019-08-23 | 2019-09-18 | CVP R | 02 | Y | 240027401 | CVP R |
| 240015671 | 240007211 | 1.67 | 70.5 | Curative (C) | 2018-08-11 | 2018-08-25 | Cisplatin + Radiotherapy | N | N | 240027447 | CISPLATIN + RT |
| 240015672 | 240007224 | 1.77 | 74.4 | Palliative (P) | 2015-03-13 | 2015-03-28 | CARBOPLATIN + PACLITAXEL | N | N | 240027497 | CARBOPLATIN + PACLITAXEL |
| 240015673 | 240007228 | 1.6 | 90.5 | Not known (9) | 2017-02-27 | 2017-02-28 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240027510 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240015674 | 240007240 | 1.8 | null | Palliative (P) | 2017-05-26 | 2017-05-28 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 240027585 | CARBOPLATIN + PACLITAXEL |
| 240015675 | 240015218 | 1.68 | 54.5 | null | 2018-07-06 | 2018-08-03 | CVP R | 02 | N | 240027623 | CVP R |
| 240015676 | 240014106 | 1.55 | 94.6 | Palliative (P) | 2014-08-11 | 2014-08-13 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240027707 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240015677 | 240007261 | 1.56 | null | Palliative (P) | 2019-05-14 | 2019-05-14 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240027715 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240015678 | 240007283 | 1.69 | 52.85 | Palliative (P) | 2016-02-18 | 2016-03-12 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240027894 | CARBOPLATIN + PACLITAXEL |
| 240015679 | 240007296 | 1.75 | 56 | Palliative (P) | 2018-02-23 | 2018-02-23 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240028055 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240015680 | 240007297 | 1.6 | null | Palliative (P) | 2017-11-20 | 2017-12-02 | CARBOPLATIN + PACLITAXEL | N | N | 240028067 | CARBOPLATIN + PACLITAXEL |
| 240015681 | 240007301 | 1.64 | 94.7 | Palliative (P) | 2018-02-10 | 2018-02-12 | CVP R | 2 | N | 240028082 | CVP R |
| 240015682 | 240011943 | 1.56 | 78.2 | Palliative (P) | 2016-05-17 | 2016-05-18 | CVP R | N | null | 240028238 | CVP R |
| 240015683 | 240011947 | 1.73 | 48.4 | Neo-adjuvant (N) | 2017-10-19 | 2017-10-19 | Carboplatin + Paclitaxel (3 weekly) | N | N | 240028305 | CARBOPLATIN + PACLITAXEL |
| 240015684 | 240011948 | 1.57 | 70.55 | Curative (C) | 2015-12-22 | 2015-12-25 | INTERLACE TRIAL | 2 | N | 240028317 | INTERLACE TRIAL |
| 240015685 | 240015230 | 1.6 | 54.5 | Curative (C) | 2019-02-21 | 2019-03-14 | Bevacizumab+Carbo+Pacliaxel | N | N | 240028402 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240015686 | 240007360 | 1.57 | 123.7 | Curative (C) | 2015-02-13 | 2015-08-22 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240028481 | NOT MATCHED |